Stockreport

Humacyte, Inc. Announces Pricing of Public Offering of Common Stock

Humacyte, Inc.  (HUMA) 
PDF DURHAM, N.C., March 25, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, b [Read more]